Description
RADIOPHARMACEUTICAL PURCHASE
First action · last action
2021-08-30 · 2022-11-06
Transactions
4
First transaction's obligation
$160,229
Base + all options value (sum of deltas)
$182,654
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25818D0051
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-08-30+$160,229= $160,229
- Mod P000012021-12-02-$14= $160,215
- Mod P000022022-03-10+$89,845= $250,060
- Mod P000032022-11-06-$67,407= $182,654
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-08-30 | +$160,229 | $160,229 | RADIOPHARMACEUTICAL PURCHASE |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-12-02 | −$14 | $160,215 | RADIOPHARMACEUTICAL PURCHASE |
| Mod P00002· FUNDING ONLY ACTION | 2022-03-10 | +$89,845 | $250,060 | RADIOPHARMACEUTICAL PURCHASE |
| Mod P00003· FUNDING ONLY ACTION | 2022-11-06 | −$67,407 | $182,654 | RADIOPHARMACEUTICAL PURCHASE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CWN9UGL3NCL9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226N0711 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $100,008 | FY2026 |
| 36C24126P0328 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $999,797 | FY2026 |
| 36C25726N0407 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $1,400,000 | FY2026 |
| 36C25526N0361 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $228,679 | FY2026 |
| 36C24426N0938 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $650,641 | FY2026 |
| 36C24426D0097 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 258-NETWORK CNTRCT OFF 22G (36C258) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25821P0342 | MCKESSON CORPORATION | 258-NETWORK CNTRCT OFF 22G (36C258) | $750 | FY2021 |
| 36C25821N0393 | UNIVERSITY OF NEW MEXICO | 258-NETWORK CNTRCT OFF 22G (36C258) | $31,866 | FY2021 |
| 36C25821P0312 | LANTHEUS MEDICAL IMAGING, INC. | 258-NETWORK CNTRCT OFF 22G (36C258) | $101,384 | FY2021 |
| 36C25821N0382 | CSL BEHRING L.L.C. | 258-NETWORK CNTRCT OFF 22G (36C258) | $152,276 | FY2021 |
| 36C25821N0374 | CHIESI USA INC | 258-NETWORK CNTRCT OFF 22G (36C258) | $75,951 | FY2021 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25821N0375_3600_36C25818D0051_3600 · retrieved 2026-09-26.